(Q46386596)

21 December 2017

title

Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease (English)

1 reference

21 December 2017

0 references

1 reference

7

1 reference

21 December 2017

Luigi Bubacco

14

1 reference

21 December 2017

Mark R Cookson

15

Mark R Cookson

1 reference

21 December 2017

8

Andrew Singleton

1 reference

21 December 2017

13

Alexandra Beilina

1 reference

21 December 2017

Gertrude-Emilia Costin

5

Gertrude-Emilia Costin

1 reference

21 December 2017

David W. Miller

12

David W Miller

1 reference

21 December 2017

Olli Hellström

10

Olli Hellström

1 reference

21 December 2017

Johanna Eerola

9

Johanna Eerola

1 reference

21 December 2017

Elisa Greggio

1

Elisa Greggio

1 reference

21 December 2017

author name string

Elisabetta Bergantino

2

1 reference

21 December 2017

Donald Carter

3

1 reference

21 December 2017

Rili Ahmad

4

1 reference

21 December 2017

Vincent J Hearing

6

1 reference

21 December 2017

Pentti J Tienari

11

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

21 December 2017

Journal of Neurochemistry

published in

1 reference

21 December 2017

volume

93

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

246-256

1 reference

21 December 2017

Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

A common temperature-sensitive allelic form of human tyrosinase is retained in the endoplasmic reticulum at the nonpermissive temperature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Tyrosinase gene expression is not detected in mouse brain outside the retinal pigment epithelium cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Confirmation of the protective effect of iNOS in an independent cohort of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Proper folding and endoplasmic reticulum to golgi transport of tyrosinase are induced by its substrates, DOPA and tyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Increased dopamine and its metabolites in SH‐SY5Y neuroblastoma cells that express tyrosinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Mammalian tyrosinase. A comparison of tyrosine hydroxylation and melanin formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Inhibition of tyrosinase reduces cell viability in catecholaminergic neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

A human TERT C-terminal polypeptide sensitizes HeLa cells to H2O2-induced senescence without affecting telomerase enzymatic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins in the initial stage of melanosome biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Conformation-dependent post-translational glycosylation of tyrosinase. Requirement of a specific interaction involving the CuB metal binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

The dark side of lysosome-related organelles: specialization of the endocytic pathway for melanosome biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Tyrosinase enhances the covalent modification of DNA by dopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Vesicles: equal in neurotransmitter concentration but not in volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Production of melanocyte-specific antibodies to human melanosomal proteins: expression patterns in normal human skin and in cutaneous pigmented lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Tyrosinase mRNA is expressed in human substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03019.X

10.1111/J.1471-4159.2005.03019.X

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017